U.S. Building Stock News

Earlier this month, Viavi Solutions launched the CyberFlood CF1000, a native 400G security and application performance test appliance designed to validate multi-terabit, AI-driven and highly encrypted data center infrastructures for equipment vendors, hyperscalers and service providers. By combining large-scale encrypted traffic generation, quantum-safe cryptography validation and AI inference workload emulation in a compact 2RU platform, the CF1000 aims to close testing gaps for complex...

Viridian Therapeutics recently reported positive topline results from its REVEAL-2 phase 3 trial, showing that elegrobart significantly improved multiple measures of chronic thyroid eye disease and was generally well tolerated, while also completing US$125,000,014 and US$225,000,000 capital raises through common stock and convertible notes offerings. The REVEAL-2 data position elegrobart as a potential at-home subcutaneous treatment for both active and chronic thyroid eye disease,...

Why CMS Energy (CMS) is on investors’ radar today CMS Energy (CMS) has drawn fresh attention after recent trading left the stock at a last close of US$72.81, with performance over the past month and past 3 months giving investors more to think about. See our latest analysis for CMS Energy. While the share price has eased in the short term, including a 1-month share price return of down 7.19%, the year-to-date share price return of 3.39% sits alongside a 1-year total shareholder return of...

Investors may be wondering whether Archrock's current share price reflects its true worth, or if the stock is starting to look stretched after a strong run. The stock finished the last session at US$36.80, with returns of 38.2% year to date and 47.2% over the past 12 months. However, it has fallen 5.9% over the last week and is roughly flat over the past month with a 0.9% gain. Recent coverage has focused on Archrock's position in energy infrastructure and how investors are reacting to...

Recent performance snapshot Blackstone Mortgage Trust (BXMT) has drawn investor attention after a mixed recent performance, with the stock last closing at US$18.43 and sitting on a market cap of about US$3.1b. Over the past month the stock is down about 6.8%, and over the past 3 months it is down about 6.7%. Year to date it is down about 5.4%, while the 1 year total return is about 4.3%. See our latest analysis for Blackstone Mortgage Trust. For investors, the picture is one of fading near...

AAR (AIR) has come into focus after recent trading, with the stock now around $107.47 and showing mixed performance, up over the past year but down over the past month and the past 3 months. See our latest analysis for AAR. For now, momentum has cooled, with the share price down 9.5% over the past week and 13.2% over the past month. This is despite the year to date share price return of 27.3% and 1 year total shareholder return of 76.0%, which point to a much stronger longer term picture. If...

Sharplink (NasdaqCM:SBET) has entered a partnership with Galaxy Digital to launch the Galaxy Sharplink Onchain Yield Fund. The fund is designed to manage Sharplink's Ethereum treasury with an institutional-grade, onchain yield approach instead of passive holding. This marks a shift in how the company handles its crypto assets, focusing on risk managed yield while maintaining Ethereum exposure. Sharplink is drawing attention by rethinking how its Ethereum holdings are used, at a time when...

StubHub Holdings stock moves: recent returns and fundamentals in focus StubHub Holdings (STUB) has drawn fresh attention after a mixed stretch in the stock, with a gain of 2.7% over the past day, a rise of 14.8% over the past month, but a decline of 14.3% over the past 3 months. At a last close of US$7.52 and a market value of about US$2.7b, the company operates a global ticketing marketplace under the StubHub and viagogo brands, with annual revenue of US$1,745.2 million and a reported net...

Gulfport Energy reported first-quarter 2026 results with revenue of US$437.53 million and net income of US$165.82 million, alongside reaffirmed full-year production guidance and completion of a large share repurchase program. The company also named former Expand Energy chief Domenic “Nick” Dell’Osso, Jr. as its incoming president and CEO, signaling continued emphasis on operational discipline and shareholder-focused capital allocation. We’ll now examine how Gulfport’s strong earnings jump...

Recent performance snapshot for Celanese (CE) Celanese (CE) has caught investor attention after a mixed recent run, with the stock roughly flat over the past 3 months, down about 12% over the past month, and up around 42% year to date. See our latest analysis for Celanese. Despite a recent 12% 1 month share price decline and softer 7 day performance, Celanese still shows stronger momentum over a longer horizon. A 42.24% year to date share price return and a 14.48% 1 year total shareholder...

Fresh Del Monte Produce (NYSE:FDP) plans to participate in the TD Cowen Future of the Consumer Conference. Senior management is scheduled for a fireside chat and one-on-one meetings with investors during the event. The conference appearance offers the company a platform to outline priorities and engage directly with the investment community. For investors tracking NYSE:FDP, this conference comes with the stock recently closing at $35.53 and posting a gain of 14.8% over the past year. Over...

Investors may be wondering whether LCI Industries at around US$110.96 is offering good value right now, or if the easy gains are already behind it. The stock has pulled back recently, with the share price down about 5.1% over the past week and 9.9% over the past month, even though the 1 year return sits at 29.7%. Recent headlines have focused on LCI Industries as investors reassess auto components stocks and their sensitivity to consumer demand and capital spending. This shifting attention...

What triggered the latest focus on Summit Therapeutics? The recent spotlight on Summit Therapeutics (SMMT) is tied to two developments: a downgrade by H.C. Wainwright following weaker interim HARMONi-3 trial signals, and first quarter results showing a net loss of US$189.42 million. See our latest analysis for Summit Therapeutics. Despite the weaker interim HARMONi-3 update and wider first quarter loss, Summit Therapeutics’ share price has slipped 6.19% over the past month but remains up...

Adecoagro (NYSE:AGRO) reported strong Q1 2026 results with its fertilizer division emerging as the main growth driver. The fertilizers segment, strengthened by the Profertil acquisition, delivered record profitability supported by higher urea prices and improved operational reliability. The company outlined an accelerated deleveraging path and confirmed a focus on sustaining dividends within a new three segment structure. Adecoagro, trading at $13.65, is coming off a strong run, with the...

Why Spire (SR) is back on investors’ radar Spire (SR) has drawn fresh attention after Wells Fargo began coverage alongside increased director share purchases, all coming shortly after the company reported profitable second quarter and six month 2026 results. See our latest analysis for Spire. At a share price of $85.56, Spire has eased in the short term, with the share price return down over the past month and quarter. However, the 1 year and multi year total shareholder returns remain...

In May 2026, QIAGEN N.V. proposed a 40% increase in its annual cash dividend to US$0.35 per share for approval at the June 24, 2026 Annual General Meeting, while also announcing plans to appoint co-founder and former CEO Dr. Metin Colpan as Honorary Chairman after he steps down from the Supervisory Board. The combination of a higher dividend, expanded shareholder return authorizations, and ongoing Supervisory Board renewal underscores how QIAGEN is pairing governance refreshment with a...

Why First BanCorp (FBP) is on investors’ radar today First BanCorp (FBP) came into focus after recent trading left the stock modestly lower over the past week, even as its year to date and 1 year total returns remain positive. See our latest analysis for First BanCorp. The recent 1 day share price decline of 1.16% and 7 day share price decline of 4.90% come after a period of steadier gains. A year to date share price return of 10.48% and a 3 year total shareholder return of 123.09% point to...

Why Cardinal Health (CAH) is back in focus after its latest quarter Cardinal Health (CAH) has moved back onto investors’ radar after its third quarter results showed a year-over-year decline in net income and a sizeable goodwill impairment tied to its Navista and ION unit. These profit and impairment headlines came alongside large pharmaceutical distribution sales, ongoing share repurchases, and an updated dividend. Together, they provide several angles to reassess how the stock fits into a...

In early May 2026, Lincoln National reported first‑quarter revenue of US$5,306 million and a net loss of US$172 million, while also announcing expanded managed account offerings with Stadion and Morningstar Retirement and deeper API integration with Centro Benefits Research to streamline broker workflows. Despite the GAAP loss, Lincoln National delivered its seventh consecutive quarter of adjusted operating income growth and continued shifting toward less market‑sensitive products, while...

PepsiCo (NasdaqGS:PEP) is acquiring prebiotic soda brand Poppi in a deal valued at $1.95b. The transaction adds a fast growing functional soda label focused on gut health to PepsiCo’s beverage lineup. The move reflects continued investment in health focused soft drinks alongside the company’s traditional soda and snack offerings. PepsiCo, which last closed at $149.27, has seen the stock rise 4.9% year to date and 20.9% over the past year, while returns over 3 years show a decline of 14.0%...

If you are wondering whether Verisk Analytics at around US$161 a share still represents good value, the current market price alone does not tell the full story. The stock is down 5.5% over the past week, 3.8% over the past month and 26.9% year to date. It has declined 46.0% over the last year and 24.9% over three years, which has shifted how many investors are thinking about both risk and potential upside. Recent headlines have focused on Verisk Analytics as a data and analytics provider in...

Commvault Systems (NasdaqGS:CVLT) is reportedly working with Goldman Sachs to review takeover interest. Potential bidders are said to include both private equity firms and industry buyers. The process is at an exploratory stage and could influence the future ownership and direction of the company. For shareholders, this comes at a time when Commvault Systems is trading at around $99.81, with the stock down 19.6% year to date and down 44.5% over the past year, while still showing a gain of...

Harrow, Inc. reported past first-quarter 2026 results with revenue of US$44.2 million versus US$47.83 million a year earlier and a wider net loss of US$27.6 million, missing analyst expectations on both revenue and earnings. Management attributed much of the revenue pressure to an US$8 million non-recurring VEVYE gross-to-net adjustment while highlighting record VEVYE prescriptions and reaffirming full-year 2026 revenue guidance of US$350 million to US$365 million. We’ll now examine how...

Why Clorox Stock Is on Investors’ Radar Today Clorox (CLX) is drawing fresh attention after recent share price moves. The stock closed at US$92.00 as investors weigh its household, health and wellness, lifestyle, and international product exposure. See our latest analysis for Clorox. The recent 1-day share price return of 3.24% and 7-day share price return of 2.21% come after a tougher patch, with the 30-day share price return down 11.02% and the 90-day share price return down 26.19%. The...